Welcome to LookChem.com Sign In|Join Free

CAS

  • or
FMOC-THR(BZL)-OH is a versatile chemical compound that combines a FMOC (9-fluorenylmethyloxycarbonyl) protecting group, a THR (threonine) amino acid residue, and a BZL (benzyl) ester group. The FMOC group is widely used in peptide synthesis to shield the N-terminal amino group and can be readily removed with a base, while the hydrophilic threonine amino acid contributes a hydroxyl group to the molecule. The BZL ester group facilitates the introduction of a carboxyl group in peptide chemistry. This unique composition positions FMOC-THR(BZL)-OH as a valuable component in the synthesis of peptides and other organic molecules, particularly within the realms of biochemistry and pharmaceuticals.

73724-48-8

Post Buying Request

73724-48-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (2S,3R)-BENZYL 2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-HYDROXYBUTANOATE

    Cas No: 73724-48-8

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

73724-48-8 Usage

Uses

Used in Peptide Synthesis:
FMOC-THR(BZL)-OH is used as a building block for the synthesis of peptides due to its incorporation of a protecting group and a hydrophilic amino acid. The FMOC group's ease of removal allows for controlled peptide chain elongation, while the threonine residue contributes to the peptide's overall properties.
Used in Biochemistry Research:
In the field of biochemistry, FMOC-THR(BZL)-OH is used as a research tool to study the interactions of amino acids and protecting groups in peptide structures. Its unique composition aids in understanding the folding, stability, and function of peptides and proteins.
Used in Pharmaceutical Development:
FMOC-THR(BZL)-OH is utilized as a component in the development of pharmaceuticals, particularly for drugs that require specific peptide sequences. Its role in peptide synthesis allows for the creation of therapeutic agents with targeted properties, such as improved bioavailability or specific binding affinities.
Used in Organic Chemistry:
In organic chemistry, FMOC-THR(BZL)-OH serves as a reagent or intermediate in the synthesis of complex organic molecules. Its functional groups can be manipulated to create a variety of chemical products, including those with potential applications in materials science or as precursors to other bioactive compounds.
Used in Drug Delivery Systems:
FMOC-THR(BZL)-OH can be employed in the design of drug delivery systems, where its peptide synthesis capabilities can be leveraged to create targeted drug carriers or to improve the stability and efficacy of therapeutic agents.
Overall, FMOC-THR(BZL)-OH's multifaceted nature makes it a valuable asset across various scientific disciplines, with applications ranging from fundamental research to the development of novel therapeutics and advanced materials.

Check Digit Verification of cas no

The CAS Registry Mumber 73724-48-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,7,2 and 4 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 73724-48:
(7*7)+(6*3)+(5*7)+(4*2)+(3*4)+(2*4)+(1*8)=138
138 % 10 = 8
So 73724-48-8 is a valid CAS Registry Number.

73724-48-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,3R)-Benzyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoate

1.2 Other means of identification

Product number -
Other names benzyl (2S,3R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-hydroxybutanoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73724-48-8 SDS

73724-48-8Downstream Products

73724-48-8Relevant articles and documents

Use of remote acyl groups for stereoselective 1,2-: Cis -glycosylation with fluorinated glucosazide thiodonors

?ervenková ??astná, Lucie,Cu?ínová, Petra,Dra?ínsky, Martin,Hamala, Vojtěch,Karban, Jind?ich,Kurfi?t, Martin

supporting information, p. 5427 - 5434 (2020/08/03)

Fluorinated glycans are valuable probes for studying carbohydrate-protein interactions at the atomic level. Glucosamine is a ubiquitous component of glycans, and the stereoselective synthesis of α-linked fluorinated glucosamine is a challenge associated with the chemical synthesis of fluorinated glycans. We found that introducing a 6-O-acyl protecting group onto 3-fluoro and 4-fluoro glucosazide thiodonors endowed them with moderate α-selectivity in the glycosylation of carbohydrate acceptors, which was further improved by adjusting the acceptor reactivity via O-benzoylation. Excellent stereoselectivity was achieved for 3,6-di-O-acyl-4-fluoro analogues. The glycosylation of threonine-derived acceptors enabled the stereoselective synthesis of the protected fluorinated analogue of α-GlcNAc-O-Thr, a moiety abundant in cell-surface O-glycans of the protozoan parasite Trypanosoma cruzi. DFT calculations supported the involvement of transient cationic species which resulted from the stabilization of the oxocarbenium ion through O-6 acyl group participation. This journal is

A Synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells

Leiria Campo, Vanessa,Riul, Thalita B.,Oliveira Bortot, Leandro,Martins-Teixeira, Maristela B.,Fiori Marchiori, Marcelo,Iaccarino, Emanuela,Ruvo, Menotti,Dias-Baruffi, Marcelo,Carvalho, Ivone

, p. 527 - 538 (2017/03/22)

This study presents the synthesis of the novel protected O-glycosylated amino acid derivatives 1 and 2, containing βGalNAc-SerOBn and βGalNAc-ThrOBn units, respectively, as mimetics of the natural Tn antigen (αGalNAc-Ser/Thr), along with the solid-phase assembly of the glycopeptides NHAcSer-Ala-Pro-Asp-Thr[αGalNAc]-Arg-Pro-Ala-Pro-Gly-BSA (3-BSA) and NHAcSer-Ala-Pro-Asp-Thr[βGalNAc]-Arg-Pro-Ala-Pro-Gly-BSA (4-BSA), bearing αGalNAc-Thr or βGalNAc-Thr units, respectively, as mimetics of MUC1 tumor mucin glycoproteins. According to ELISA tests, immunizations of mice with βGalNAc-glycopeptide 4-BSA induced higher sera titers (1:320 000) than immunizations with αGalNAc-glycopeptide 3-BSA (1:40 000). Likewise, flow cytometry assays showed higher capacity of the obtained anti-glycopeptide 4-BSA antibodies to recognize MCF-7 tumor cells. Cross-recognition between immunopurified anti-βGalNAc antibodies and αGalNAc-glycopeptide and vice versa was also verified. Lastly, molecular dynamics simulations and surface plasmon resonance (SPR) showed that βGalNAc-glycopeptide 4 can interact with a model antitumor monoclonal antibody (SM3). Taken together, these data highlight the improved immunogenicity of the unnatural glycopeptide 4-BSA, bearing βGalNAc-Thr as Tn antigen isomer.

α-Selective glycosylation affords mucin-related GalNAc amino acids and diketopiperazines active on Trypanosoma cruzi

Martins-Teixeira, Maristela B.,Campo, Vanessa L.,Biondo, Monica,Sesti-Costa, Renata,Carneiro, Zumira A.,Silva, Jo?o S.,Carvalho, Ivone

, p. 1978 - 1987 (2013/05/08)

This work addresses the synthesis and biological evaluation of glycosyl diketopiperazines (DKPs) cyclo[Asp-(αGalNAc)Ser] 3 and cyclo[Asp-(αGalNAc)Thr] 4 for the development of novel anti-trypanosomal agents and Trypanosoma cruzi trans-sialidase (TcTS) inhibitors. The target compounds were synthetized by coupling reactions between glycosyl amino acids αGalNAc-Ser 7 or αGalNAc-Thr 8 and the amino acid (O-tBu)-Asp 17, followed by one-pot deprotection-cyclisation reaction in the presence of 20% piperidine in DMF. The protected glycosyl amino acid intermediates 7 and 8 were, in turn, obtained by α-selective, HgBr2-catalysed glycosylation reactions of Fmoc-Ser/Thr benzyl esters 12/14 with αGalN3Cl 11, being, subsequently, fully deprotected for comparative biological assays. The DKPs 3 and 4 showed relevant anti-trypanosomal effects (IC50 282-124 μM), whereas glycosyl amino acids 1 and 2 showed better TcTS inhibition (57-79%) than the corresponding DKPs (13-25%).

Influence of steric parameters on the synthesis of tetramates from α-amino-β-alkoxy-esters and Ph3PCCO

Loke, Inga,Park, Natja,Kempf, Karl,Jagusch, Carsten,Schobert, Rainer,Laschat, Sabine

, p. 697 - 704 (2012/01/05)

α-Aminoesters react with Ph3PCCO in a domino addition-Wittig cyclization sequence affording enantiomerically pure tetramates. In the case of β-oxo functionalized α-aminoesters, e.g., esters of serine, threonine or β-hydroxyornithine the yields of this reaction depend heavily on the bulkiness of the β-OR group and on the configuration of β-carbon atom C-3. Smaller residues and 2R/3R-configured aminoesters give better yields. The alkoxycarbonyl group of the ester moiety and the residue on the N-atom are less important. These findings can be accounted for by assuming an early puckered transition state for the intramolecular ring-closing Wittig reaction. The addition of sub-stoichiometric amounts of benzoic acid or N-hydroxysuccinimide (for acid-sensitive compounds) is advantageous in some cases as it accelerates the formation of the intermediate amide ylides.

Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase

Campo, Vanessa L.,Sesti-Costa, Renata,Carneiro, Zumira A.,Silva, Jo?o S.,Schenkman, Sergio,Carvalho, Ivone

body text, p. 145 - 156 (2012/02/15)

This work describes the synthesis of a series of sialylmimetic neoglycoconjugates represented by 1,4-disubstituted 1,2,3-triazole-sialic acid derivatives containing galactose modified at either C-1 or C-6 positions, glucose or gulose at C-3 position, and by the amino acid derivative 1,2,3-triazole fused threonine-3-O-galactose as potential TcTS inhibitors and anti-trypanosomal agents. This series was obtained by Cu(I)-catalysed azide-alkyne cycloaddition reaction ('click chemistry') between the azido-functionalized sugars 1-N3-Gal (commercial), 6-N 3-Gal, 3-N3-Glc and 3-N3-Gul with the corresponding alkyne-based 2-propynyl-sialic acid, as well as by click chemistry reaction between the amino acid N3-ThrOBn with 3-O-propynyl-GalOMe. The 1,2,3-triazole linked sialic acid-6-O-galactose and the sialic acid-galactopyranoside showed high Trypanosoma cruzi trans-sialidase (TcTS) inhibitory activity at 1.0 mM (approx. 90%), whilst only the former displayed relevant trypanocidal activity (IC50 260 μM). These results highlight the 1,2,3-triazole linked sialic acid-6-O-galactose as a prototype for further design of new neoglycoconjugates against Chagas' disease.

Chemical and chemoenzymatic synthesis of glycosyl-amino acids and glycopeptides related to Trypanosoma cruzi mucins

Campo, Vanessa Leiria,Carvalho, Ivone,Allman, Sarah,Davis, Benjamin G.,Field, Robert A.

, p. 2645 - 2657 (2008/03/12)

This study describes the synthesis of the α- and β-linked N-acetyllactosamine (Galp-β-1,4-GlcNAc; LacNAc) glycosides of threonine (LacNAc-Thr). LacNAc-α-Thr was prepared by direct chemical coupling of a 2-azido-2-deoxy-lactose disaccharide donor to a suitable partially protected threonine unit. In contrast, stepwise chemical generation of β-linked N-acetylglucosamine followed by enzymatic galactosylation to give LacNAc-β-Thr proved effective, whereas use of a 2-azido-2-deoxy-lactose donor in acetonitrile failed to give the desired β-linked disaccharyl glycoside. This study illustrates that it is possible to overcome the inherent stereoselection for 1,2-trans chemical glycosylation with a GlcNAc donor, and that the well-established preference of bovine β-1,4-galactosyltransferase for β-linked acceptor substrates can also be overcome. Using this knowledge, short glycopeptide fragments based on T. cruzi mucin sequences, Thr-Thr-[LacNAcThr]-Thr-Thr-Gly, were synthesised. All LacNAc-based compounds outlined were shown to serve as acceptor substrates for sialylation by T. cruzi trans-sialidase. The Royal Society of Chemistry.

Synthesis of mannosyl and oligomannosyl threonine building blocks found on the mycobacterium tuberculosis 45 kDa MPT 32 glycoprotein

Varon, Daniel,Lioy, Eduardo,Patarroyo, Manuel E.,Schratt, Xaver,Unverzagt, Carlo

, p. 161 - 165 (2007/10/03)

Mycobacterium tuberculosis secretes a 45 kDa glycoprotein (MPT 32) carrying mannosylated threonine residues. A general strategy was developed to couple peracetylated mannose, α-(1,2)-linked mannobiose or mannotriose to Fmoc-threonine-benzyl ester. Activation of mannosyl acetates or fluorides by borontrifluoride etherate gave the desired Fmoc-glycosyl amino acid building blocks in good yields. The synthesis leads to stable compounds and can easily be scaled up.

Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin

Mitchell,Pratt,Hruby,Polt

, p. 2327 - 2342 (2007/10/03)

The synthesis of 18 N-α-FMOC-amino acid glycosides for solid-phase glycopeptide assembly is reported. The glycosides were synthesized either from the corresponding O'Donnell Schiff bases or from N-α-FMOC-amino protected serine or threonine and the appropriate glycosyl bromide using Hanessian's modification of the Koenigs-Knorr reaction. Reaction rates of D-glycosyl bromides (e.g., acetobromoglucose) with the L- and D-forms of serine and threonine are distinctly different and can be rationalized in terms of the steric interactions within the two types of diastereomeric transition states for the D/L and D/D reactant pairs. The N-α-FMOC-protected glycosides [monosaccharides Xyl, Glc, Gal, Man, GlcNAc, and GalNAc; disaccharides Gal-β(1-4)-Glc (lactose), Glc-β(1-4)-Glc (cellobiose), and Gal-α(1-6)-Glc (melibiose)] were incorporated into 22 enkephalin glycopeptide analogues. These peptide opiates bearing the pharmacophore H-Tyr-c[DCys-Gly-Phe-DCys]- were designed to probe the significance of the glycoside moiety and the carbohydrate-peptide linkage region in blood-brain barrier (BBB) transport, opiate receptor binding, and analgesia.

Chemical Synthesis of Some Mono- and Digalactosyl O-Glycopeptides

Lacombe, J. M.,Pavia, A. A.

, p. 2557 - 2563 (2007/10/02)

Chemical synthesis of several O-glycopeptides containing O-galactosylthreonine are reported.Two different approaches have been investigated to determine the strategy best adapted to the synthesis of any desired O-glycopeptide.Glycosylation of an adequatel

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 73724-48-8